VANCOUVER, May 16, 2019 /CNW/ - LeanLife Health Inc. (CSE: LLP) (the "Company") a Company focused on proprietary plant-based food products is pleased to announce that the Company has shipped its first product samples.
LeanLife's Omega-3 product was shipped to Europe via air courier. The samples will be distributed by LeanLife's existing salesforce to numerous customers that have been waiting for them in order to evaluate its use in their food production. Potential customers receiving samples include some of Europe's largest producers of bread, pasta, cheese, yogurt, and butter.
ARYZTA AG, one of the largest producers of frozen bakery products in the world, previously sold loaves of bread and rolls containing an earlier version of LeanLife's proprietary Omega-3 product produced in Poland. This followed several months of testing, technological studies and measurement of satisfactory consumer acceptance by ARYZTA. At the time the bread and rolls containing LeanLife's product were introduced to over 2,700 stores.
A recent trial application of LeanLife's Omega-3 product as a direct substitute for vegetable oil in the production of chocolate muffins demonstrated its ease of use and great taste. A single muffin contained a sufficient supply of this essential food ingredient to meet the daily dose needs for adults to maintain overall health. Omega-3 fatty acids are essential because the body cannot make them on its own and so they must be consumed from dietary sources.
The samples were produced as part of LeanLife's recent testing phase which exceeded the company's expectations in the areas of quality and efficiency. The successful production of samples also confirmed LeanLife's large scale production capability and readiness to fulfill orders following the validation of samples by buyers.
Samples were also sent to SGS, the world's leading inspection, verification, testing and certification company, for independent confirmation of the product's quality and specifications previously identified by the Simon Fraser University ("SFU") Faculty of Chemistry.
The samples were produced at Ecovatec Solutions Inc. ("Ecovatec"), a local Canadian nutraceutical manufacturing company.
"We are very excited to be back in production. Now that LeanLife is capable of producing in large volumes, the shipping of samples to potential customers that have been waiting for our product brings the Company to the verge of revenue generation in this multi-billion dollar market. Our salesforce in Europe has been eagerly awaiting the opportunity to revisit potential customers. As the awareness of the importance of healthy eating continues to expand, LeanLife intends to meet the growing consumer demand for plant-based essential food ingredients. The Company is also looking forward to receiving independent verification by SGS of the preliminary analysis of the product quality and specifications," said Stan Lis, CEO.
The Company also announces that 3.5 million options are being granted at $0.045.
About LeanLife Health and the Omega-3 Market
LeanLife Health's products are shelf-stable extractions from flax seed, a plentiful plant-based source of Omega-3, that give them a significant advantage as a fortified food ingredient.
The products can be used as food additives or as nutraceuticals and have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market.
LeanLife Health's industry leading and proprietary Omega-3 product formulations are of the highest quality and contain no cholesterol. Products are available in oil, emulsion and powder forms.
The global Omega-3 market reached USD $33 Billion in 2016 and is expected to reach upwards of USD $57 Billion by 2025, according to a report by Grand View Research, Inc.
Forward Looking Information
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control including, the Company's ability to compete with large food companies; sales of any potential products developed will be profitable; the ability to complete sales under the sales agreement. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
THE CSE HAS NEITHER APPROVED NOR DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE LeanLife Health Inc.
For further information: Stan Lis, CEO, 604-764-0518, SLis@LeanLifeHealth.com